Arrhythmias & electrophysiologyMeta-analysis

Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials

EuropacePublished

  • Systematic review and meta-analysis of randomised controlled trials
  • random-effects models
  • GRADE certainty of evidence

Authors' conclusion

In patients with AF, LAAC results in a higher risk of ischaemic stroke or systemic embolism than an OAC-based strategy. Compared with OAC, LAAC has no effect on major bleeding or mortality and does not reduce haemorrhagic stroke.

Study context

Population
Patients with atrial fibrillation (AF)
Participants
7,004 patients · 6 randomized controlled trials (RCTs)
Comparison
Left atrial appendage closure (LAAC) vs oral anticoagulation (OAC)
  • LAACn = 3,681
  • OACn = 3,323reference

Pooled result

Ischaemic stroke or systemic embolism

Relative risk

1.41

95% CI 1.07–1.86

Events by group

LAAC

134

events

OAC

80

events

LAAC vs OAC
RR 1.41 (95% CI 1.07–1.86)

As reported in the abstract

Safety

OutcomeRR (95% CI)
Nonprocedural clinically relevant bleeding · high CoE; reduced with LAAC0.50 (0.43–0.59)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials. Europace. Published 23 July 2026. doi:10.1093/europace/euag159

Summarised from the published abstract; every number is checked against it